133

Last update : 09/05/2017

CONNECT - Observational study of adherence to european clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non revascularized patients

Head : Herrmann Marie-Annick, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Main objective

Management of acute coronary syndromes and adequation to international guidelines at the acute phase and at hospital discharge, according to the realization or not of a percutaneous coronary revascularization

Inclusion criteria

Patient >= 18 years, hospitalized in cardiology for ACS with or without ST-segment elevation, selected the day of hospital discharge

Last update : 09/05/2017

IMPACT - Determinants of the non-control of blood pressure in overweighted treated hypertensive patients

Head : Vignal Franck, Sanofi Aventis

Version 1

134

Last update : 01/01/2019

IMPACT - Determinants of the non-control of blood pressure in overweighted treated hypertensive patients

Head : Vignal Franck, Sanofi Aventis

Main objective

Find the determinants of the non-control of blood pressure in treated hypertensive patients who are overweight or obese compared to treated hypertensive patients of normal weight

Inclusion criteria

Man or woman, over the age of 18 years, Having essential high blood pressure (HBP) treated for at least 1 year, Having a BMI < 25 kg/m² for patients of normal weight, Having a BMI ≥ 25 kg/m² for overweight or obese patients

Last update : 01/01/2019

ARIANE - Arixtra and platelet monitoring (Study of the actual usage of Arixtra® 2, 5 mg in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

135

Last update : 01/01/2019

ARIANE - Arixtra and platelet monitoring (Study of the actual usage of Arixtra® 2, 5 mg in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Evaluate and compare in general practice the level of prescription for platelet monitoring of patients receiving Arixtra® 2.5 mg (fondaparinux sodium) or an LMWH (low-molecular-weight heparin) in venous thromboprophylaxis.

Inclusion criteria

• Patient of at least 18 years of age
• Bedridden patient or with reduced mobility
Patient for whom a treatment via ARIXTRA® 2.5 mg or an LMWH is initiated within the framework of venous thromboprophylaxis

Last update : 01/01/2019

EFG Senior - Influenza burden assessment in adults aged of 65 years and more visiting a general practitioner for acute respiratory illness in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

136

Last update : 01/01/2020

EFG Senior - Influenza burden assessment in adults aged of 65 years and more visiting a general practitioner for acute respiratory illness in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Describe and compare the burden of acute respiratory infections (IRA) linked to influenza virus, in terms of morbidity and medical consumption, according to the vaccinal status, in those 65 years and older spontaneously consulting in general practice

Inclusion criteria

• Patient aged 65 years or older
• Patient having an acute respiratory infection defined as a clinical presentation combining the abrupt appearance of respiratory signs (coughing, rhinitis, coryza) in the context of acute infection (fever, asthenia, headache, myalgia, etc.), in less than 48h.

• For patients 80 years and older, the clinical presentations can associate other general signs (mental confusion, dehydration, anorexia, digestive disorders, general malaise, body aches, headache) and respiratory signs (from rhinitis to pneumopathy)

Last update : 01/01/2020

ATHMOS - Validation of the ACT questionnaire in general practice

Head : Pribil Céline, Laboratoire GSK

Version 1

137

Last update : 01/01/2018

ATHMOS - Validation of the ACT questionnaire in general practice

Head : Pribil Céline, Laboratoire GSK

Main objective

Describe in actual practice the level of control of asthma using the ACT questionnaire (Asthma Control Test)

Inclusion criteria

Male or female aged 18 years or older
Patient having asthma diagnosed at least 12 months ago
Patient informed of the objectives of the study and accepting the collection and the analysis of the data concerning him.

Last update : 01/01/2018

EDITH - Observational study to evaluate educational modality of type 2 diabetic patients at the time of insulin initiation by GPs

Head : Vignal Franck, Sanofi Aventis

Version 1

138

Last update : 01/01/2018

EDITH - Observational study to evaluate educational modality of type 2 diabetic patients at the time of insulin initiation by GPs

Head : Vignal Franck, Sanofi Aventis

Main objective

describe the effects on the fasting glucose at 1 month for main methods of education of type-2 diabetes patients during the initiation of insulin therapy in general practice

Inclusion criteria

man or woman, over the age of 18 years, having a type-2 diabetes responding to the criteria of HAS (French National Authority for Health), treated with oral diabetes medication at the maximum dose (or maximum tolerated dose where applicable), having needed the adding of a basal insulin initiated since at least 1 month and no more than 6 months (+ 1 week) before inclusion, reviewed 1 month after the initiation of insulin, during a routine visit in the framework of following his or her diabetes, accepting to participate in the study after information given by the observing doctor.

Last update : 01/01/2018